Leadership & Co-Founders
JNL Biopharmaceutics' leadership team holds the vital expertise for biologics. We accelerate biologics success by uniting advanced scientific knowledge, extensive industry relationships, and commercial marketing strategy.
Experts at JNL Biopharmaceutics handle everything from contract execution to efficient market entry, keeping our core focus exactly where it belongs: on the quality of our medications.
JNL Biopharmaceutics was established at the intersection of international visions coming together, Dutch expertise and Jordanian enthusiasm. Built on a foundation of elite academic training and years of high-level industry experience, the company is driven by a clear strategic vision and unwavering work ethics.
Under the visionary leadership of our co-founder and CEO, Dr. Willem de Weerd, JNL Biopharmaceutics is poised to elevate its Research & Development to unprecedented heights of scientific excellence in the MENA market.
JNL Biopharmaceutics’ co-founder, Rana Shahin, excels at adapting plans based on practical realities while ensuring every step remains aligned with our goal.
Through collaboration, our vision will become a reality.
Dr. Willem De Weerd
Co-Founder & CEO
Dr. Willem De Weerd, through his scientific education and extensive experience in the pharma industry, he is uniquely qualified to lead JNL Biopharmaceutics through the entire lifecycle—from initial drug design and early research to the creation of viable development pipelines. Dr. De Weerd brings scientific innovation while enabling commercial viability.
Rana Shahin
Co-founder &
Chief Operations Manager
Mrs. Rana Shahin is an attorney in Jordan, specializing in Intellectual Property. She first launched her career at Hikma Pharmaceuticals, where she gained firsthand insight into the pharmaceutical industry. This experience led her to pursue an LL.M. in Intellectual Property from George Washington University.